GSK PLC (LSE:GSK)
£ 18.1 0.105 (0.58%) Market Cap: 73.81 Bil Enterprise Value: 87.49 Bil PE Ratio: 17.87 PB Ratio: 5.33 GF Score: 77/100

GlaxoSmithKline PLC at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 03:30PM GMT
Release Date Price: £18.18 (-0.27%)
James Daniel Gordon
JP Morgan Chase & Co, Research Division - Senior Analyst

Good morning. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, I've got the pleasure of introducing the GSK presentation. So you're going to hear from GSK CEO, Emma Walmsley, and we're going to have a breakout behind this room in the Borgia afterwards. So I hope you can join us for the Q&A. So with that said, thanks very much for joining us and look forward to the presentation.

Emma N. Walmsley
GlaxoSmithKline plc - CEO & Director

Good morning, everybody, and thank you very much, James. Thanks to you all for joining us here early this morning. So first of all, let me just refer you to our cautionary statement.

When I became CEO of GSK in 2017, I laid out my 3 long-term priorities for the company: innovation, performance and trust, all to be powered by a necessary change in culture. Initially, it was simply a framework. And though there remains much more to do, we're now demonstrating good progress on these priorities.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot